Shares of Health Care sector company Zimmer Biomet moved 0.3% today, and are now trading at a price of $120.29. The large-cap stock's daily volume was 1,364,821 compared to its average volume of 1,812,434. The S&P 500 index returned a 0.0% performance.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company is based in Warsaw and has 18,000 full time employees. Its market capitalization is $25,138,323,456. Zimmer Biomet currently offers its equity investors a dividend that yields 0.8% per year.
24 analysts are following Zimmer Biomet and have set target prices ranging from $99.0 to $149.0 per share. On average, they have given the company a rating of hold. At today's prices, ZBH is trading -7.21% away from its average analyst target price of $129.63 per share.
Over the last year, ZBH shares have gone down by -5.6%, which represents a difference of -28.5% when compared to the S&P 500. The stock's 52 week high is $149.25 per share and its 52 week low is $102.0. Although Zimmer Biomet's average free cash flow over the last 6 years has been $1.26 Billion, they have been decreasing at an average rate of -6.6%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 1,237,400 | 291,700 | 945,700 | -19.05 |
| 2022 | 1,356,200 | 187,900 | 1,168,300 | -13.82 |
| 2021 | 1,499,200 | 143,600 | 1,355,600 | 24.07 |
| 2020 | 1,204,500 | 111,900 | 1,092,600 | -21.25 |
| 2019 | 1,585,800 | 198,400 | 1,387,400 | -12.45 |
| 2018 | 1,747,400 | 162,700 | 1,584,700 |
